Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels.… Continue Reading
Since COVID-19 first emerged as a global pandemic, the pharmaceutical industry has risen to meet the virus’ related challenges from a prevention as well as a treatment perspective. Continue Reading
The COVID-19 pandemic has been characterized by surges in infections in different parts of the country at different times. The most recent rebound of COVID cases, however, indicates that the COVID-19 pandemic is not just a series of isolated surges that is “one and done.” Continue Reading
19. As in COVID. Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. Continue Reading
As of October 2, 2020, the novel coronavirus has infected more than 34 million people, including President Donald J. Trump and First Lady Melania Trump, and killed over one million, resulting in a global economic decline on a scale not… Continue Reading
